US medtech industry warns of potential devastating effect of FDA proposed policy change
This article was originally published in SRA
Executive Summary
A policy change the US Food and Drug Administration is proposing in the medical devices arena could have a devastating effect on emerging companies, with particularly drastic implications for sponsors of devices subject to 510(k) clearance.